These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 15319086

  • 21. Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs.
    Hoshino Y, Pesnicak L, Dowdell KC, Burbelo PD, Knipe DM, Straus SE, Cohen JI.
    J Infect Dis; 2009 Oct 01; 200(7):1088-95. PubMed ID: 19702506
    [Abstract] [Full Text] [Related]

  • 22. The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes.
    Bernstein DI, Pullum DA, Cardin RD, Bravo FJ, Dixon DA, Kousoulas KG.
    Vaccine; 2019 Jan 03; 37(1):61-68. PubMed ID: 30471955
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2.
    Quenelle DC, Collins DJ, Marciani DJ, Kern ER.
    Vaccine; 2006 Mar 06; 24(10):1515-22. PubMed ID: 16288820
    [Abstract] [Full Text] [Related]

  • 27. Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
    Leone P.
    Curr Med Res Opin; 2005 Oct 06; 21(10):1577-82. PubMed ID: 16238897
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Status quo of the researches on HSV vaccines].
    Gao J, Lu JC, Huang YF.
    Zhonghua Nan Ke Xue; 2009 Jan 06; 15(1):60-4. PubMed ID: 19288753
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Preventing herpes simplex virus transmission to the neonate.
    Brown Z.
    Herpes; 2004 Aug 06; 11 Suppl 3():175A-186A. PubMed ID: 15319088
    [Abstract] [Full Text] [Related]

  • 33. An Interleukin 12 Adjuvanted Herpes Simplex Virus 2 DNA Vaccine Is More Protective Than a Glycoprotein D Subunit Vaccine in a High-Dose Murine Challenge Model.
    Bagley KC, Schwartz JA, Andersen H, Eldridge JH, Xu R, Ota-Setlik A, Geltz JJ, Halford WP, Fouts TR.
    Viral Immunol; 2017 Apr 06; 30(3):178-195. PubMed ID: 28085634
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A Herpes Simplex Virus 2 (HSV-2) gD Mutant Impaired for Neural Tropism Is Superior to an HSV-2 gD Subunit Vaccine To Protect Animals from Challenge with HSV-2.
    Wang K, Goodman KN, Li DY, Raffeld M, Chavez M, Cohen JI.
    J Virol; 2016 Jan 01; 90(1):562-74. PubMed ID: 26559846
    [Abstract] [Full Text] [Related]

  • 39. Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D.
    Awasthi S, Shaw C, Friedman H.
    Expert Rev Vaccines; 2014 Dec 01; 13(12):1475-88. PubMed ID: 25138572
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.